Connect your AI

Organon OGN Total Liabilities

Total Liabilities at other companies

PfizerPFE

$3.41B-97.1%

The Cooper Companies, Inc.COO

$4.24B+2.9%

BiogenBIIB

$305.1M-97.2%

PBH

Prestige Consumer HealthcarePBH

$1.61B+2.5%

ViatrisVTRS

$22.18B-2.8%

AmgenAMGN

——

Other financials

Income statement

Revenue$1.5B-3.5%

Gross profit$783.0M-6.9%

Net income$146.0M+67.8%

EPS (diluted)$0.55+66.7%

Balance sheet

Cash & equivalents$1.1B+104%

Total debt$8.6B-4.3%

Total equity$903.0M+66.6%

Total assets$13.0B-1.2%

Cash flow

Operating cash flow$225.0M+200%

CapEx$37.0M+15.6%

Free cash flow$188.0M+337%

Valuation

Market cap$3.53B-59.4%

Profitability

Gross margin52.8%-4.4pp

Net margin8%-12.3pp

FCF margin11.1%-1.3pp

Returns & leverage

Return on equity71.6%—

Debt / equity9.5×-7.0×

Current ratio2×+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Organon's total liabilities?: Organon (OGN) reported total liabilities of $12.09B in Q1 2026.
How has Organon's total liabilities changed year-over-year?: Organon's total liabilities decreased by 4.1% year-over-year, from $12.61B to $12.09B.
What is the long-term trend for Organon's total liabilities?: Over 3 years (2022 to 2025), Organon's total liabilities has grown at a 0.7% compound annual growth rate (CAGR), from $11.85B to $12.12B.
What does total liabilities mean?: The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.